If you’ve been battling treatment-resistant depression, you already know how exhausting it is to keep searching for something that works. If you have found Spravato and are wondering if insurance cover the cost of Spravato, the good news is that Spravato (esketamine) is covered by most major insurance plans, including Medicare, Medicaid, and commercial insurers like Aetna, Cigna, Blue Cross Blue Shield, and UnitedHealthcare. Coverage does come with requirements, but it is very real and very accessible for qualifying patients.
Here is a full breakdown of what to expect.
Spravato is an FDA-approved nasal spray version of esketamine. It treats adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with acute suicidal ideation. Unlike traditional antidepressants, it works through the NMDA receptor in the brain. It can bring relief within hours rather than weeks.
Because Spravato must be administered in a certified clinical setting with medical monitoring, it is not a simple prescription you fill at your local pharmacy. That clinical supervision adds to the cost. Without insurance, a single dose can cost between $700 and $1,200, depending on the dose and facility. The first month of treatment, which may include twice-weekly sessions, can run $5,000 to $8,000 out of pocket.
That is a real barrier. Insurance coverage changes everything.
Yes. Most major insurance plans now cover Spravato for patients who meet their clinical criteria. Here is how coverage breaks down by plan type.
In a 2025 review of 18 major commercial insurers, every single one had a written policy that covered Spravato for depression. That list includes:
Nearly all require prior authorization. You will also need to demonstrate that you have tried at least 2 different antidepressants that did not provide adequate relief.
Insurance companies do not simply cover Spravato for any patient who asks. For insurance cover the cost of Spravato, they require documentation that establishes medical necessity. Most major carriers look for the following:
Your clinical team at Autumn Leaves Psychiatry handles this documentation process on your behalf. Our team submits prior authorization requests, follows up with your insurance carrier, and advocates for approval. You should not have to fight that battle alone while you are already fighting depression.
Denials happen, but they are not the end of the road. Insurance companies often deny claims on initial submission. The appeals process exists specifically for situations like this. With complete documentation of your treatment history and clinical need, many denials are overturned. If you want to understand the steps involved in getting a prescription and building that documentation trail, our blog on how to get a Spravato prescription walks through the process in detail.
Yes. The manufacturer of Spravato, Janssen Pharmaceuticals, offers the SPRAVATO withMe Savings Program. Eligible commercially insured patients may pay as little as $10 per treatment for the medication cost, with a maximum program benefit of $8,150 per calendar year. This program is for commercially insured patients only and does not apply to Medicare or Medicaid beneficiaries. For patients who are uninsured or whose coverage does not meet their needs, Johnson and Johnson’s Patient Assistance Program may allow eligible individuals to receive the medication at no cost for up to one year if they meet income requirements.
Understanding insurance is complicated enough without adding a new diagnosis and a new treatment to the mix. The team at Autumn Leaves Psychiatry works directly with your insurance to verify benefits before you begin treatment. We help identify your coverage structure, submit prior authorization requests, and keep you informed throughout the approval process. Our goal is to remove as many barriers as possible so that you can focus on getting better.
Treatment-resistant depression is hard enough without also trying to decode insurance paperwork. You deserve support on both fronts. If you are wondering whether Spravato might be right for you, or if you are ready to find out whether your insurance covers it, reach out to us. Our team will help you understand your options and move forward with confidence.
Autumn Leaves Psychiatry is located in Idaho Falls, Idaho. We offer compassionate, personalized psychiatric care, including Spravato esketamine therapy, medication management, TMS, and telehealth services. You do not have to figure this out alone.
Almost always, yes. Nearly every major insurance carrier, including Medicare Advantage, Medicaid, and commercial plans, requires prior authorization before approving Spravato treatments. The prior authorization process involves submitting clinical documentation that confirms your diagnosis and treatment history. Your care team at Autumn Leaves Psychiatry handles this process on your behalf to minimize delays and avoid unnecessary denials.
No. The SPRAVATO withMe Savings Program is designed for commercially insured patients only. It does not apply to those with Medicare, Medicaid, Tricare, or other government-funded insurance programs. If you have Medicare or Medicaid, coverage through your plan is the primary path to managing costs. In some cases, supplemental Medigap coverage or state-specific assistance programs may help reduce your remaining out-of-pocket expenses. Ask our team about your specific situation.
If you do not yet meet your insurance plan’s criteria, your provider may be able to document additional treatment history or request a peer-to-peer review with your insurer. Some patients also appeal initial denials successfully when additional clinical documentation is provided. In cases where commercial coverage is not an option, the Johnson and Johnson Patient Assistance Program may cover the cost of medication for eligible uninsured or underinsured patients for up to one year. Your care coordinator can help you explore every available option.
If you have any questions or would like to set up an appointment, please don't hesitate to reach out.